Advertisement

First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability and survival

Tomas Pika, Ute Hegenbart, Pavla Flodrova, Bettina Maier, Christoph Kimmich and Stefan O. Schönland

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview